Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03328858 · ClinicalTrials.gov registry record · NA
Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor
A NA study, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03328858: Clinical Trial NA study, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
NCT03328858 is a NA study that was terminated before completion, run by Nicklaus Children's Hospital f/k/a Miami Children's Hospital. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03328858, a NA study, was terminated before completion, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of the ketogenic diet on tumor size and quality of life in pediatric patients with malignant or recurrent/refractory brain tumors.
Primary Outcome
To evaluate the overall response rate of subjects with malignant or refractory brain tumors receiving dietary therapy with the ketogenic diet
Interventions
- OTHER Ketogenic Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Why NCT03328858 stopped before completion
NCT03328858 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Ketogenic Diet is the first listed.
NCT03328858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03328858 about?
NCT03328858 is a clinical study titled "Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor". The purpose of this study is to evaluate the effect of the ketogenic diet on tumor size and quality of life in pediatric patients with malignant or recurrent/refractory brain tumors.
What is the current status of trial NCT03328858?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-11-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03328858?
The interventions under investigation include: Ketogenic Diet (OTHER).
Who is sponsoring clinical trial NCT03328858?
This trial is sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03328858's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI